首页|中医药调控AQP2防治糖尿病肾病相关进展

中医药调控AQP2防治糖尿病肾病相关进展

扫码查看
糖尿病肾病(Diabetic kidney disease,DKD)是糖尿病(Diabetes mellitus,DM)的主要并发症之一,其严重影响DM患者生存周期和生活质量。目前,现有DKD的一线治疗方案并不能有效阻止DKD的发生发展。中医药在治疗DKD中具有"多途径、多靶点、多通路"的优势,在治疗DKD中有着广阔前景。水通道蛋白-2(AQP2)是在肾脏广泛表达的膜通道蛋白,其生理作用与肾蒸腾气化的功能高度相似。研究发现,中药多种有效成分和相关复方可通过抑制AQP2的异常表达,改善DKD患者相关症状。该文就AQP2在DKD中的作用机制及中医药干预研究进展进行综述,以期为DKD相关防治药物的研发提供思路和参考。
Progress in the Regulation of Aquaporin-2 by Traditional Chinese Medicine for the Prevention and Treatment of Diabetic Nephropathy
Diabetic kidney disease(DKD)is one of the major complications of diabetes mellitus(DM),which significantly affects the survival and quality of life of DM patients.Currently,existing first-line treatment approaches for DKD are ineffective in effectively preventing the occurrence and progression of DKD.Traditional Chinese medicine(TCM)has the advantages of"ultiple pathways,multiple targets,and multiple mechanisms"in treating DKD,and has a broad prospect in the treatment of DKD.Aquaporin-2(AQP2)is a membrane channel protein widely expressed in the kidneys,and its physiological function is highly similar to the function of kidney filtration and reabsorption.Studies have found that various effective components and related formulae of Chinese medicine can improve symptoms in DKD patients by inhibiting the abnormal expression of AQP2.This article provides a review on the role of AQP2 in DKD and the research progress of TCM intervention,aiming to provide insights and references for the development of drugs related to the prevention and treatment of DKD.

Traditional Chinese medicineDiabetic kidney diseaseDiabetes mellitusAquaporin-2Overview

章溥、张尚祖、朱向东、唐立洪、段永强、白敏、赵芸慧、梁建庆

展开 >

甘肃中医药大学基础医学院 兰州 730000

宁夏区域高发病中医药防治教育部重点实验室 银川 750004

宁夏医科大学附属中医医院 吴忠 751100

中医药 糖尿病肾病 糖尿病 水通道蛋白-2 综述

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(11)